EIKN
Eikon Therapeutics, Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 3/30/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| SCHEDULE 13G | 2/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EIKN |
| Company Name | Eikon Therapeutics, Inc. |
| CIK | 1861123 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 341-777-0566 |